A new article from a team at @MIT examines why current machine learning approaches consistently underperform in decoding small molecule structures from mass spectrometry data. Published in Nature Metabolism, the article identified three key failures >>> Why machine learning still can't crack small molecule structures - Bioanalysis Zone (hubs.ly/Q04l4Yjs0)

Will Dakshat Trivedi win your support? Check out the finalists’ profiles and help us choose the 2026 bioanalysis rising star! 🏆 hubs.ly/Q04hV42J0 #BRSA2026

In this Application Note, @SartoriusGlobal demonstrate how the enhanced data acquisition rate on the Octet® R8e can be used to generate more accurate data for low-affinity interactions across a range of temperatures relative to steady-state analysis. Download now >>>hubs.ly/Q04hspD30

Streamline your PROTAC quantification by leveraging a unified platform that handles acquisition, processing and reporting without switching systems. Discover @SCIEXnews OS software with built-in compliance and intelligent automation, delivering faster, cleaner results in a single validated environment >>> hubs.ly/Q04gMFZc0

Will Giorgi Kobidze win your support? Check out the finalists’ profiles and help us choose the 2026 bioanalysis rising star! 🏆 hubs.ly/Q04hTWP_0 #BRSA2026

In this expert opinion, @QPSHoldingsLLC’s Zamas Lam breaks down the critical trade-offs between lipid nanoparticles and viral vectors for gene-based therapeutic delivery. The article explores immunogenicity risks, transduction efficiency, manufacturing considerations, and provides guidance on modality selection based on therapeutic goals >>> hubs.ly/Q04hgtzj0

An update on the latest M&A deals impacting bioanalysis! The most recent biopharma partnerships and acquisitions reflect several key industry trends: ➡️The race to develop innovative cancer treatments through advanced modalities like antibody-drug conjugates (ADCs) and multi-specific antibodies. ➡️Expansion into underserved therapeutic areas including rare diseases and women’s health. ➡️The growing importance of cross-border collaborations that combine Eastern discovery capabilities with Western commercial scale. In this article, we review some of the latest deals impacting pharma and biotech 👉 hubs.ly/Q04kD6sW0

Will Ethan Sanford win your support? Check out the finalists’ profiles and help us choose the 2026 bioanalysis rising star! 🏆 hubs.ly/Q04hSZdn0 #BRSA2026

📢 New Meeting Report! An update on the European Bioanalysis Forum recommendation on singlicate analysis for ligand binding assays: biomarker and anti-drug-antibody assays. Read more about the article: hubs.ly/Q04k75fc0

Will Richa Pandey win your support? Check out the finalists’ profiles and help us choose the 2026 bioanalysis rising star! 🏆 hubs.ly/Q04hSGQ10 #BRSA2026

⏳ Have you voted yet? Time’s ticking — listen to the four Bioanalysis Rising Star Award finalists present their cases and cast your vote for who you think should win. Have your say now >>> hubs.ly/Q04hTJt80🏆🌟 #BRSA2026

Tech Note: Sensitive analysis of the PROTAC degrader ARV-110 in rat plasma. Download now and uncover how the @SCIEXnews 7500 system's improved front-end technology enables simplified PROTAC bioanalysis in complex matrices >>> hubs.ly/Q04gMPZq0

🌟 Four finalists. One rising star. Your choice! 🌟 Voting for the Bioanalysis Rising Star Award is LIVE! hubs.ly/Q04hV2hb0 These finalists represent the next generation of scientific excellence — make your vote count! 🗳️ #BioanalysisRisingStar #BRSA2026 #VoteToday

Navigate the trade-offs between LNPs and viral vectors for gene-based therapeutic delivery. Zamas Lam, Senior Vice President at @QPSHoldingsLLC , shares his tips for choosing the right delivery vehicle. Make an informed decision for your therapeutic >>> hubs.ly/Q04hgcJ80

Interested in enzyme technology? Then don’t miss the latest webinars, products, resources and more from Wothington Biochecmical Corporation. Check out their company profile on BioTechniques here! >>> hubs.ly/Q04hSLhf0

Announced this week at the 74th ASMS conference, @SCIEXnews has introduced the novus V55 system, a triple quadrupole mass spectrometer that promises to lend a hand to high-pressure, results-driven labs. Compared to its predecessors, the system is designed to deliver exceptional sensitivity and accelerated output in a more compact and energy-efficient design, expanding testing capabilities across a wide range of applications, including pesticide analysis, pharmaceutical impurity detection and PFAS testing. Find out more about the instrument here: bit.ly/43I14ie

Have you read the latest Tech Note from @SCIEXnews? Check out ‘Low-ng/mL quantitation of GLP-1 analog in rat plasma’ to discover methods that demonstrate how optimized triple quadrupole mass spectrometry enables selective, reproducible measurement of high‑potency peptide therapeutics in complex matrices. >>> hubs.ly/Q04fMsJW0

As a leader in translational biomarkers and bioanalytical science with a focus on oncology, Zone Leader Heather Myler brings hands-on experience spanning PK, immunogenicity, LC/MS and flow cytometry. In this interview, Heather shares her perspective on a recent and highly impactful manuscript, what topics The Zone should home in on this year, and what the bioanalytical lab might look like in 10 years—spoiler: it involves less manual data wrangling and more time for actual science. Read the full interview: hubs.ly/Q04jJfyX0

A successful approach to biomarker discovery and analysis depends on multiple factors, including effective sample collection and advanced technologies for data interpretation. In this interview, Professor Melanie Bailey shares her expert perspective on the critical role of sample collection and explains how her lab tackles biomarker discovery in translational research. Read the full interview with Melanie here: hubs.ly/Q04jd6kt0 @WatersCorp

Sartorius demonstrates the benefits of the enhanced data acquisition rate on the Octet® R8e in their latest Application Note. Download to learn more >>>hubs.ly/Q04hsqYj0